ADVERTISEMENT

Getting patients to talk about priapism

Current Psychiatry. 2003 July;02(07):61-71
Author and Disclosure Information

Mr. Q, a college sophomore, stops taking his anxiolytic after experiencing a 4-hour erection. The problem: He’s too embarrassed to tell his psychiatrist about the episode, which could impair his sexual function.

Mr. Q’s priapism resolved spontaneously with no apparent erectile dysfunction. He was referred back to the university health service and has been in apparent good health since.

Related resources

Drug brand names

  • Bupropion • Wellbutrin
  • Chlorpromazine • Thorazine
  • Clozapine • Clozaril
  • Fluphenazine • Prolixin
  • Haloperidol • Haldol
  • Labetalol • Trandate
  • Levomepromazine • Nozinan
  • Mesoridazine • Serentil
  • Metoclopramide • Reglan
  • Molindone • Lidone
  • Perphenazine • Trilafon
  • Phenelzine • Nardil
  • Prazosin • Minipress
  • Promazine • Sparine
  • Risperidone • Risperdal
  • Sertraline • Zoloft
  • Sildenafil citrate • Viagra
  • Thioridazine • Mellaril
  • Thiothixene • Navane
  • Trazodone • Desyrel

Disclosure

Dr. Freed reports no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.

Dr. Muskin receives research/grant support from Bristol-Myers Squibb Co., is a speaker for and consultant to Bristol-Myers Squibb Co., Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, and Pfizer Inc.; and is a speaker for Cephalon Inc. and Eli Lilly and Co.